These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32339484)

  • 41. Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2022 Apr; 108():65-68. PubMed ID: 34973207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
    López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
    J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What Goes In Must Come Out: A Mixed-Method Study of Access to Contraceptive Implant Removal Services in Ghana.
    Callahan R; Lebetkin E; Brennan C; Kuffour E; Boateng A; Tagoe S; Coolen A; Chen M; Aboagye P; Brunie A
    Glob Health Sci Pract; 2020 Jun; 8(2):220-238. PubMed ID: 32606092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pilot study on the effect of isotretinoin on serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Seale R; Davis A; Guiahi M
    Contraception; 2020 Jul; 102(1):58-60. PubMed ID: 32325076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
    Wilson S; Tennant C; Sammel MD; Schreiber C
    Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
    Mutihir JT; Nyango DD
    East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors Associated With Delayed Contraceptive Implant Removal in Ethiopia.
    Costenbader E; Cartwright AF; McDowell M; Assefa B; Tejeji MY; Tenaw E
    Glob Health Sci Pract; 2020 Sep; 8(3):455-465. PubMed ID: 33008846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
    Chen MJ; Hsia JK; Creinin MD
    Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Davis A; Swartz M; Guiahi M
    Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Best Practices for Counseling Adolescents about the Etonogestrel Implant.
    Berlan ED; Richards MJ; Vieira CS; Creinin MD; Kaunitz AM; Fraser IS; Edelman A; Mansour D
    J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):448-454. PubMed ID: 32621879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Etonogestrel Implant in Adolescents: Factors Associated With Removal for Bothersome Bleeding in the First Year After Insertion.
    Green S; Sheeder J; Richards M
    J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):825-831. PubMed ID: 34089858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy.
    Lazorwitz A; Coleman-Minahan K; Teal SB; Guiahi M
    J Adolesc Health; 2018 Sep; 63(3):363-364. PubMed ID: 30076014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrasound characteristics of subdermally implanted Implanon contraceptive rods.
    Lantz A; Nosher JL; Pasquale S; Siegel RL
    Contraception; 1997 Nov; 56(5):323-7. PubMed ID: 9437562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Floyd JL; Beasley AD; Swaim LS; Turrentine MA; Nijjar JB
    Obstet Gynecol; 2020 Jun; 135(6):1275-1280. PubMed ID: 32459418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implant removal experience with Sino-implant (II) at four Chinese sites.
    Cheng L; Steiner MJ; Meng H; Luo D; Zhong Y; Cheng Y; Chen G; Ni H; Feldblum PJ
    Contraception; 2014 Sep; 90(3):249-52. PubMed ID: 24965314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Removal of non-palpable etonogestrel implants.
    Mansour D; Walling M; Glenn D; Egarter C; Graesslin O; Herbst J; Fraser IS
    J Fam Plann Reprod Health Care; 2008 Apr; 34(2):89-91. PubMed ID: 18413020
    [No Abstract]   [Full Text] [Related]  

  • 59. Compound versus fundamental imaging in the detection of subdermal contraceptive implants.
    Gabriel H; Shulman L; Marko J; Nikolaidis P; Chirita V
    J Ultrasound Med; 2007 Mar; 26(3):355-9. PubMed ID: 17324985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What is needed to improve quality of implant removal services in Nigeria? results of a landscape assessment.
    Adetiloye O; Danladi A; Haws R; Anoke C; Odio B; Ugwa E; Nganje A; Enne J; Afolabi K; Adebola O; Eze J; Christofield M
    Front Glob Womens Health; 2023; 4():1082969. PubMed ID: 37034399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.